Sodium-glucose cotransporter 2 inhibitors are associated with reduced circulating activin A and modulation of BMP/activin signaling in ischemic cardiomyopathy with high echocardiographic probability of pulmonary hypertension.
- DOI
- 10.1007/s11357-026-02497-0
- Published
- 2026 Aug 31
- Container
- GeroScience
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11357-026-02497-0,
title = {Sodium-glucose cotransporter 2 inhibitors are associated with reduced circulating activin A and modulation of BMP/activin signaling in ischemic cardiomyopathy with high echocardiographic probability of pulmonary hypertension.},
author = {Madonna R and Del Boccio P and Borghini A and Alberti M and Biondi F and Cufaro MC and Morganti R and Pieragostino D and Andreassi MG and Rocca C and Ferdinandy P and Mattii L and Angelone T and De Caterina R},
year = {2026},
journal = {GeroScience},
doi = {10.1007/s11357-026-02497-0},
url = {https://doi.org/10.1007/s11357-026-02497-0}
}RIS
TY - JOUR TI - Sodium-glucose cotransporter 2 inhibitors are associated with reduced circulating activin A and modulation of BMP/activin signaling in ischemic cardiomyopathy with high echocardiographic probability of pulmonary hypertension. AU - Madonna R AU - Del Boccio P AU - Borghini A AU - Alberti M AU - Biondi F AU - Cufaro MC AU - Morganti R AU - Pieragostino D AU - Andreassi MG AU - Rocca C AU - Ferdinandy P AU - Mattii L AU - Angelone T AU - De Caterina R PY - 2026 JO - GeroScience DO - 10.1007/s11357-026-02497-0 UR - https://doi.org/10.1007/s11357-026-02497-0 ER -
APA
R, M., P, D. B., A, B., M, A., F, B., MC, C., R, M., D, P., MG, A., C, R., P, F., L, M., T, A., & R, D. C. (2026). Sodium-glucose cotransporter 2 inhibitors are associated with reduced circulating activin A and modulation of BMP/activin signaling in ischemic cardiomyopathy with high echocardiographic probability of pulmonary hypertension.. GeroScience. https://doi.org/10.1007/s11357-026-02497-0
Source records
- pubmed · retrieved 2026-09-26T09:59:06.597Z